Treatment for functional constipation begins with nonpharmacological management. This includes education and lifestyle modifications, such as diet changes, consistent exercise, and guidance on proper body position and behavior when using the restroom. The first treatments for constipation are dietary guidelines, which include the requirement for a regular consumption of
fiber and fluids. A normal intake of fiber is advocated for children with functional constipation, as per the criteria of ESPGHAN/NASPGHAN. It is not recommended to increase the consumption of fiber above what is considered normal. In order to effectively treat childhood constipation, it is imperative that parents and children receive counseling. This includes teaching them about the concept of
overflow incontinence and the significance of withholding behavior. Children with functional constipation can be treated pharmacologically in two stages: maintenance therapy and faecal disimpaction. High-dose oral
polyethylene glycol (PEG) or
enemas containing active substances such
sodium phosphate,
sodium lauryl sulfoacetate, or
sodium docusate can be used to induce fecal disimpaction. Maintenance therapy is suggested following successful disimpaction in order to avoid reoccurring stool buildup. Adults rarely need faecal disimpaction, although the methods are comparable, and substantial doses of PEG or
magnesium citrate are popular oral therapies. For both adults and children,
glycerine or
bisacodyl suppositories provide an alternative to
enemas. Other often used laxatives include
milk of magnesia (
magnesium hydroxide) and
mineral oil, a lubricant. Functional constipation has been treated with a variety of 5-hydroxytryptamine 4 (5-HT4) agonists. Additionally, serotonin promotes motility by stimulating the mucosa's afferent neurons, which in turn triggers the
gastrocolic reflex. == Research ==